Follow
David Larson
David Larson
Unknown affiliation
Verified email at horizontherapeutics.com
Title
Cited by
Cited by
Year
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
DJ Jackson, WW Busse, LB Bacharier, M Kattan, GT O’Connor, RA Wood, ...
Journal of Allergy and Clinical Immunology 146 (1), 203-206. e3, 2020
6532020
BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation
A Bononi, C Giorgi, S Patergnani, D Larson, K Verbruggen, M Tanji, ...
Nature 546 (7659), 549-553, 2017
4062017
Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study
SM Jones, EH Kim, KC Nadeau, A Nowak-Wegrzyn, RA Wood, ...
The Lancet 399 (10322), 359-371, 2022
1782022
Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma
A Napolitano, L Pellegrini, A Dey, D Larson, M Tanji, EG Flores, ...
Oncogene 35 (15), 1996-2002, 2016
1762016
Consensus report of the 2015 Weinman international conference on mesothelioma
M Carbone, S Kanodia, A Chao, A Miller, A Wali, D Weissman, A Adjei, ...
Journal of thoracic oncology 11 (8), 1246-1262, 2016
1642016
Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β
MP Hübner, Y Shi, MN Torrero, E Mueller, D Larson, K Soloviova, ...
The journal of immunology 188 (2), 559-568, 2012
1332012
Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS, S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared …
VA Stewart, SM McGrath, PM Dubois, MG Pau, P Mettens, J Shott, ...
Infection and immunity 75 (5), 2283-2290, 2007
1272007
Biomarkers of severity and threshold of allergic reactions during oral peanut challenges
AF Santos, G Du Toit, C O’Rourke, N Becares, N Couto-Francisco, ...
Journal of Allergy and Clinical Immunology 146 (2), 344-355, 2020
1252020
Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression
H Yang, L Pellegrini, A Napolitano, C Giorgi, S Jube, A Preti, CJ Jennings, ...
Cell death & disease 6 (6), e1786-e1786, 2015
792015
Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy
MH Shamji, D Larson, A Eifan, GW Scadding, T Qin, K Lawson, ML Sever, ...
Journal of Allergy and Clinical Immunology 148 (4), 1061-1071. e11, 2021
692021
CD200R surface expression as a marker of murine basophil activation
MN Torrero, D Larson, MP Hübner, E Mitre
Clinical & Experimental Allergy 39 (3), 361-369, 2009
662009
HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
L Pellegrini, J Xue, D Larson, S Pastorino, S Jube, KH Forest, ...
Oncotarget 8 (14), 22649, 2017
632017
Chronic helminth infection reduces basophil responsiveness in an IL-10–dependent manner
D Larson, MP Hübner, MN Torrero, CP Morris, A Brankin, ...
The Journal of Immunology 188 (9), 4188-4199, 2012
632012
Basophils amplify type 2 immune responses, but do not serve a protective role, during chronic infection of mice with the filarial nematode Litomosoides sigmodontis
MN Torrero, MP Hübner, D Larson, H Karasuyama, E Mitre
The Journal of immunology 185 (12), 7426-7434, 2010
612010
Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice
MP Hübner, D Larson, MN Torrero, E Mueller, Y Shi, KE Killoran, E Mitre
Clinical Immunology 141 (2), 205-217, 2011
452011
Investigating palygorskite’s role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity
D Larson, A Powers, JP Ambrosi, M Tanji, A Napolitano, EG Flores, ...
Journal of Toxicology and Environmental Health, Part B 19 (5-6), 213-230, 2016
402016
The MALT1 locus and peanut avoidance in the risk for peanut allergy
A Winters, HT Bahnson, I Ruczinski, MP Boorgula, C Malley, AR Keramati, ...
Journal of Allergy and Clinical Immunology 143 (6), 2326-2329, 2019
392019
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial
J Corren, D Larson, MC Altman, RM Segnitz, PC Avila, PA Greenberger, ...
Journal of Allergy and Clinical Immunology 151 (1), 192-201, 2023
362023
Nasal allergen challenge and environmental exposure chamber challenge: a randomized trial comparing clinical and biological responses to cat allergen
D Larson, P Patel, AM Salapatek, P Couroux, D Whitehouse, A Pina, ...
Journal of Allergy and Clinical Immunology 145 (6), 1585-1597, 2020
322020
Helminth infection is associated with decreased basophil responsiveness in human beings
D Larson, PJ Cooper, MP Hübner, J Reyes, M Vaca, M Chico, HH Kong, ...
Journal of allergy and clinical immunology 130 (1), 270-272, 2012
322012
The system can't perform the operation now. Try again later.
Articles 1–20